Outcomes and Surgical Considerations for Neurosurgical Patients Hospitalized with COVID-19-A Multicenter Case Series
- PMID: 34237448
- PMCID: PMC8257398
- DOI: 10.1016/j.wneu.2021.06.147
Outcomes and Surgical Considerations for Neurosurgical Patients Hospitalized with COVID-19-A Multicenter Case Series
Abstract
Objective: Neurosurgical patients are at a higher risk of having a severe course of coronavirus disease 2019 (COVID-19). The objective of this study was to determine morbidity, hospital course, and mortality of neurosurgical patients during the coronavirus disease 2019 (COVID-19) pandemic in a multicenter health care system.
Methods: A retrospective observational study was conducted to identify all hospitalized neurosurgical patients positive for COVID-19 from March 11, 2020 to November 2, 2020 at Mayo Clinic and the Mayo Clinic Health System.
Results: Eleven hospitalized neurosurgical patients (0.68%) were positive for COVID-19. Four patients (36.6%) were men and 7 (63.3%) were women. The mean age was 65.7 years (range, 35-81 years). All patients had comorbidities. The mean length of stay was 13.4 days (range, 4-30 days). Seven patients had a central nervous system malignancy (4 metastases, 1 meningioma, 1 glioblastoma, and 1 schwannoma). Three patients presented with cerebrovascular complications, comprising 2 spontaneous intraparenchymal hemorrhages and 1 ischemic large-vessel stroke. One patient presented with an unstable traumatic spinal burst fracture. Four patients underwent neurosurgical/neuroendovascular interventions. Discharge disposition was to home in 5 patients, rehabilitation facility in 3, and hospice in 3. Five patients had died at follow-up, 3 within 30 days from COVID-19 complications and 2 from progression of their metastatic cancer.
Conclusions: COVID-19 is rare among the inpatient neurosurgical population. In all cases, patients had multiple comorbidities. All symptomatic patients from the respiratory standpoint had complications during their hospitalization. Deaths of 3 patients who died within 30 days of hospitalization were all related to COVID-19 complications. Neurosurgical procedures were performed only if deemed emergent.
Keywords: COVID; Coronavirus; Neurosurgery; Neurosurgical.
Copyright © 2021 Elsevier Inc. All rights reserved.
Figures




Similar articles
-
COVID-19 Impact on Neurosurgical Practice: Lockdown Attitude and Experience of a European Academic Center.World Neurosurg. 2020 Dec;144:e380-e388. doi: 10.1016/j.wneu.2020.08.168. Epub 2020 Sep 3. World Neurosurg. 2020. PMID: 32891850 Free PMC article.
-
The Impact of the Coronavirus Disease 2019 Pandemic on Neurosurgical Practice and Feasibility of Safe Resumption of Elective Procedures During this Era in a Large Referral Center in Tehran, Iran: An Unmatched Case-Control Study.World Neurosurg. 2021 Oct;154:e370-e381. doi: 10.1016/j.wneu.2021.07.047. Epub 2021 Jul 17. World Neurosurg. 2021. PMID: 34284156 Free PMC article.
-
Neurosurgical Procedures and Safety During the COVID-19 Pandemic: A Case-Control Multicenter Study.World Neurosurg. 2020 Nov;143:e179-e187. doi: 10.1016/j.wneu.2020.07.093. Epub 2020 Jul 20. World Neurosurg. 2020. PMID: 32702490 Free PMC article.
-
Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.World Neurosurg. 2021 Sep;153:e187-e194. doi: 10.1016/j.wneu.2021.06.071. Epub 2021 Jun 22. World Neurosurg. 2021. PMID: 34166828 Free PMC article.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
Cited by
-
Coronavirus disease-19 is associated with decreased treatment access and worsened outcomes in malignant brain tumor patients.Surg Neurol Int. 2023 Aug 18;14:292. doi: 10.25259/SNI_440_2023. eCollection 2023. Surg Neurol Int. 2023. PMID: 37680935 Free PMC article.
-
SARS-CoV-2 M Protein Facilitates Malignant Transformation of Breast Cancer Cells.Front Oncol. 2022 Jun 7;12:923467. doi: 10.3389/fonc.2022.923467. eCollection 2022. Front Oncol. 2022. PMID: 35747796 Free PMC article.
-
A prospective evaluation of postoperative fever in adult neurosurgery patients in the COVID-19 era.J Clin Neurosci. 2022 Sep;103:26-33. doi: 10.1016/j.jocn.2022.06.024. Epub 2022 Jul 4. J Clin Neurosci. 2022. PMID: 35809454 Free PMC article.
-
Extracellular vesicles derived from SARS-CoV-2 M-protein-induced triple negative breast cancer cells promoted the ability of tissue stem cells supporting cancer progression.Front Oncol. 2024 Mar 7;14:1346312. doi: 10.3389/fonc.2024.1346312. eCollection 2024. Front Oncol. 2024. PMID: 38515582 Free PMC article.
-
Association of major postoperative wound and anastomotic complications in thoracic surgery with COVID-19 infection.Surg Open Sci. 2022 Oct;10:208-215. doi: 10.1016/j.sopen.2022.10.008. Epub 2022 Nov 7. Surg Open Sci. 2022. PMID: 36373161 Free PMC article.
References
-
- World Health Organization Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/?gclid=CjwKCAiAouD_BRBIEiwALhJH6Pxm7_w27zRA2DVO_... Available at:
-
- Díaz-Bello S., Hernández-Hernández A., Guinto-Nishimura G.Y., et al. Reconversion of neurosurgical practice in times of the SARS-CoV-2 pandemic: a narrative review of the literature and guideline implementation in a Mexican neurosurgical referral center. Neurosurg Focus. 2020;49:E4. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical